| # | Drug | Count |
|---|---|---|
| 0 | VEMURAFENIB | 105 |
| 1 | ADALIMUMAB | 54 |
| 2 | METHOTREXATE SODIUM | 50 |
| 3 | METHOTREXATE | 46 |
| 4 | NIVOLUMAB | 46 |
| 5 | INFLIXIMAB | 37 |
| 6 | ASPIRIN | 33 |
| 7 | ASPIRIN 325 MG | 33 |
| 8 | ASPIRIN 81 MG | 33 |
| 9 | PEMBROLIZUMAB | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALITRETINOIN | 3 | 0.0252 |
| 1 | MENTHOL AND BENZOCAINE | 1 | 0.0185 |
| 2 | AMLODIPINE AND VALSARTAN | 2 | 0.0102 |
| 3 | HALOBETASOL PROPIONATE AND TAZAROTENE | 2 | 0.0101 |
| 4 | VEMURAFENIB | 105 | 0.0088 |
| 5 | FERROUS FUMARATE AND POLYSACCHRIDE IRON VITAMIN MINERAL COMPLEX SUPPLEMENT | 1 | 0.0051 |
| 6 | PROPAFENONE | 20 | 0.0047 |
| 7 | CALCIPOTRIENE | 13 | 0.0036 |
| 8 | TAPINAROF | 7 | 0.0035 |
| 9 | ACITRETIN | 17 | 0.0034 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aryl Hydrocarbon Receptor Agonist [EPC] | 7 | 0.0035 |
| 1 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 3 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 4 | Nitrogen Binding Agent [EPC] | 2 | 0.0008 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 78 | 0.0008 |
| 6 | Vitamin D Analog [EPC] | 14 | 0.0008 |
| 7 | Provitamin D2 Compound [EPC] | 23 | 0.0008 |
| 8 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 9 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |